Literature DB >> 23558621

Antigen depots: T cell traps?

Sacha Gnjatic, Nina Bhardwaj.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23558621     DOI： 10.1038/nm.3113

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  11 in total

1.  Inflammasome-independent role of the apoptosis-associated speck-like protein containing CARD (ASC) in the adjuvant effect of MF59.

Authors:  Ali H Ellebedy; Christopher Lupfer; Hazem E Ghoneim; Jennifer DeBeauchamp; Thirumala-Devi Kanneganti; Richard J Webby
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-26       Impact factor: 11.205

Review 2.  Adjuvants and antibody production: dispelling the myths associated with Freund's complete and other adjuvants.

Authors:  Harold F Stills
Journal:  ILAR J       Date:  2005

Review 3.  T cell exhaustion.

Authors:  E John Wherry
Journal:  Nat Immunol       Date:  2011-06       Impact factor: 25.606

4.  Peptide vaccine induces enhanced tumor growth associated with apoptosis induction in CD8+ T cells.

Authors:  Daisuke Muraoka; Takuma Kato; Linan Wang; Yuka Maeda; Takuro Noguchi; Naozumi Harada; Kazuyoshi Takeda; Hideo Yagita; Philippe Guillaume; Immanuel Luescher; Lloyd J Old; Hiroshi Shiku; Hiroyoshi Nishikawa
Journal:  J Immunol       Date:  2010-08-23       Impact factor: 5.422

5.  CD8+ T cell priming by dendritic cell vaccines requires antigen transfer to endogenous antigen presenting cells.

Authors:  Alice W Yewdall; Scott B Drutman; Felecia Jinwala; Keith S Bahjat; Nina Bhardwaj
Journal:  PLoS One       Date:  2010-06-16       Impact factor: 3.240

6.  Cancer immunotherapy: moving beyond current vaccines.

Authors:  Steven A Rosenberg; James C Yang; Nicholas P Restifo
Journal:  Nat Med       Date:  2004-09       Impact factor: 53.440

7.  Dendritic cell antigen presentation drives simultaneous cytokine production by effector and regulatory T cells in inflamed skin.

Authors:  James B McLachlan; Drew M Catron; James J Moon; Marc K Jenkins
Journal:  Immunity       Date:  2009-02-05       Impact factor: 31.745

8.  Adjuvanticity of the oil-in-water emulsion MF59 is independent of Nlrp3 inflammasome but requires the adaptor protein MyD88.

Authors:  Anja Seubert; Samuele Calabro; Laura Santini; Barbara Galli; Alessia Genovese; Sara Valentini; Susanna Aprea; Annalisa Colaprico; Ugo D'Oro; Marzia M Giuliani; Michele Pallaoro; Mariagrazia Pizza; Derek T O'Hagan; Andreas Wack; Rino Rappuoli; Ennio De Gregorio
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-20       Impact factor: 11.205

9.  Phase I trial of overlapping long peptides from a tumor self-antigen and poly-ICLC shows rapid induction of integrated immune response in ovarian cancer patients.

Authors:  Paul Sabbatini; Takemasa Tsuji; Luis Ferran; Erika Ritter; Christine Sedrak; Kevin Tuballes; Achim A Jungbluth; Gerd Ritter; Carol Aghajanian; Katherine Bell-McGuinn; Martee L Hensley; Jason Konner; William Tew; David R Spriggs; Eric W Hoffman; Ralph Venhaus; Linda Pan; Andres M Salazar; Catherine Magid Diefenbach; Lloyd J Old; Sacha Gnjatic
Journal:  Clin Cancer Res       Date:  2012-10-02       Impact factor: 12.531

10.  Persistent antigen at vaccination sites induces tumor-specific CD8⁺ T cell sequestration, dysfunction and deletion.

Authors:  Yared Hailemichael; Zhimin Dai; Nina Jaffarzad; Yang Ye; Miguel A Medina; Xue-Fei Huang; Stephanie M Dorta-Estremera; Nathaniel R Greeley; Giovanni Nitti; Weiyi Peng; Chengwen Liu; Yanyan Lou; Zhiqiang Wang; Wencai Ma; Brian Rabinovich; Ryan T Sowell; Kimberly S Schluns; Richard E Davis; Patrick Hwu; Willem W Overwijk
Journal:  Nat Med       Date:  2013-03-03       Impact factor: 53.440
View more
  2 in total

Review 1.  Cancer vaccines: Trafficking of tumor-specific T cells to tumor after therapeutic vaccination.

Authors:  Yared Hailemichael; Willem W Overwijk
Journal:  Int J Biochem Cell Biol       Date:  2014-05-02       Impact factor: 5.085

2.  Enhancing adoptive CD8 T cell therapy by systemic delivery of tumor associated antigens.

Authors:  Ditte E Jæhger; Mie L Hübbe; Martin K Kræmer; Gael Clergeaud; André V Olsen; Camilla Stavnsbjerg; Mette N Wiinholt; Andreas Kjær; Jonas R Henriksen; Anders E Hansen; Thomas L Andresen
Journal:  Sci Rep       Date:  2021-10-05       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.